Jay Edelberg

Director/Board Member bij Prolaio, Inc.

Health Technology

Consumer Services

Actieve functies van Jay Edelberg

Bedrijven	Functie	Begin	Einde
Prolaio, Inc. Prolaio, Inc. BiotechnologyHealth Technology Prolaio, Inc. is a company founded in 2021 that engages in research and development of medical. The company is based in Scottsdale, AZ.	Director/Board Member	-	-
	Corporate Secretary	-	-

Bedrijven	Functie	Begin	Einde
MYOKARDIA, INC.	Chief Tech/Sci/R&D Officer	-	01-11-2020
SANOFI	Corporate Officer/Principal	-	-

Duke University

Doctorate Degree

Internationaal

Verenigde Staten	4
Frankrijk	2

Operationeel

Corporate Officer/Principal	1
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Sectoraal

Health Technology	4
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
SANOFI	Health Technology

Bedrijven in privébezit	2
MyoKardia, Inc. MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA.	Health Technology
Prolaio, Inc. Prolaio, Inc. BiotechnologyHealth Technology Prolaio, Inc. is a company founded in 2021 that engages in research and development of medical. The company is based in Scottsdale, AZ.	Health Technology

Bedrijven in privébezit

Health Technology